Principal Investigator
Digestive System Department
Division of General Internal Medicine
更新時間：2023-09-19
- Co-Principal Investigator
- Clinical Trial Experience (year) 17 years 9 個月
-
jyhmingliou@gmail.com
Highlights
2. Involved in the Taipei global consensus for gastric cancer prevention (Gut 2020;69:2093-2112)
3. Secretary General of the Asian Pacific Alliance on Helicobacter and Microbiota (APAHAM)
4. Steering committee member (Sequential versus triple therapy for the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial, clarithromycin, amoxicillin, metronidazole, lansoprazole)
5. Global leading PI (Comparison of vonoprazan-based versus lansoprazole-based triple therapy, high dose dual therapy, bismuth and non-bismuth quadruple therapy in the first-line treatment of Helicobacter pylori infection -a multicenter, open labelled,randomized pilot trial, vonoprazan, lansoprazole)
Study Area
- Gastrointestinal cancer
- Helicobacter pylori infection
Professional Experiences
Clinical Professor
Department of Internal Medicine
Attending Physician
Division of Gastroenterology, Department of Internal Medicine
Education
Graduate Institute of Epidemiology and Preventive Medicine, College of Public Health
Ph.D.
School of Medicine, College of Medicine
M.D.
Clinical Trials List
2016
Total 5
-
I 1
-
I/II 0
-
II 0
-
II/III 0
-
III 4
-
IV 0
-
Others 0
Number of Studies by Scale
0件
Taiwan Multiple Center
Taiwan Single Center
0Cases
Taiwan Multiple Center
0Cases
Multi-Regional Multi-Center
6Cases
